DY
DY2.F Dentsply Sirona Inc
- Market cap
- EUR 1.69B
- P/E
- -
- P/B
- 1.37x
- ROE
- 2.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is DY2.F undervalued?
Graham numberThe Graham number of Dentsply Sirona Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Dentsply Sirona Inc fundamental analysis
No fundamental analysis for Dentsply Sirona Inc yet.
Dentsply Sirona Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Dentsply Sirona Inc
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and o…
Full company profileDentsply Sirona Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Dentsply Sirona Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 3.75B | 3.99B | 3.99B | 4.03B | 3.34B | 4.25B | 3.92B | 3.97B | 3.79B | 3.68B | 3.49B |
| Gross Profit | 2.00B | 2.19B | 2.07B | 2.17B | 1.66B | 2.36B | 2.13B | 2.09B | 1.96B | 1.84B | 1.82B |
| Operating Income | 478M | 514M | 349M | 442M | 222M | 639M | 364M | 289M | 188M | 252M | 200M |
| EBITDA | - | -1.25B | -590M | 698M | 322M | 960M | -667M | 249M | -518M | -46.0M | 497M |
| Net Income | 430M | -1.55B | -1.01B | 263M | -83.0M | 421M | -950M | -132M | -910M | -598M | 33.3M |
| EPS | - | -6.83 | -4.53 | 1.19 | -0.38 | 1.94 | -4.41 | -0.62 | -4.58 | -3.00 | 0.17 |
| Balance Sheet | |||||||||||
| Total Assets | 11.7B | 10.4B | 8.69B | 8.60B | 9.34B | 9.22B | 7.64B | 7.37B | 5.75B | 5.43B | 5.19B |
| Total Liabilities | 3.53B | 3.75B | 3.55B | 3.51B | 4.37B | 4.18B | 3.83B | 4.08B | 3.81B | 4.09B | 3.84B |
| Shareholders' Equity | 8.11B | 6.62B | 5.12B | 5.09B | 4.97B | 5.04B | 3.81B | 3.29B | 1.94B | 1.34B | 1.36B |
| Cash & Short-term Investments | 384M | 321M | 310M | 405M | 438M | 339M | 365M | 334M | 272M | 326M | 195M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 563M | 602M | 500M | 639M | 649M | 657M | 517M | 377M | 461M | 235M | 228M |
| Capital Expenditure | 126M | 144M | 183M | 123M | 87.0M | 142M | 149M | 149M | 180M | 131M | 171M |
| Free Cash Flow | - | 451M | 312M | 510M | 548M | 515M | 368M | 228M | 281M | 104M | 57.3M |
| Ratios | |||||||||||
| ROE | 5.3% | -23.4% | -19.7% | 5.2% | -1.7% | 8.3% | -24.9% | -4.0% | -46.9% | -44.7% | 2.5% |
| ROA | 3.7% | -14.9% | -11.6% | 3.1% | -0.9% | 4.6% | -12.4% | -1.8% | -15.8% | -11.0% | 0.6% |
| Net Profit Margin | 11.5% | -38.8% | -25.4% | 6.5% | -2.5% | 9.9% | -24.2% | -3.3% | -24.0% | -16.3% | 1.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Dentsply Sirona Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Dec 29, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 128M | 0.64 | - |
| 2024 | USD 126M | 0.63 | - |
| 2023 | USD 116M | 0.55 | - |
| 2022 | USD 104M | 0.48 | - |
| 2021 | USD 92.0M | 0.42 | 21.9% |
| 2020 | USD 88.0M | 0.40 | - |
| 2019 | USD 81.0M | 0.37 | 30.8% |
| 2018 | USD 79.0M | 0.35 | - |
| 2017 | USD 78.3M | 0.35 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Dentsply Sirona Inc
- Insiders 0.65%
- Institutions 99.35%
- Public & others 0.00%
- Shares outstanding 199M
- Free float 187M
Dentsply Sirona Inc company profile
- Company name
- Dentsply Sirona Inc
- Ticker
- DY2.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 14,000
- Fiscal year end
- December
- Address
- 13320 Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607
- Phone
- 844 848 0137
- Website
- dentsplysirona.com
About Dentsply Sirona Inc
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
Dentsply Sirona Inc management
10- Mr. Daniel T. ScavillaPresident, CEO, Interim Principal Financial Officer & Director · born 1965
- Ms. Andrea L. FrohningSenior VP & Chief Human Resources Officer · born 1970
- Mr. Robert Anthony JohnsonSenior VP & Chief Supply Chain Officer · born 1969
- Mr. Aldo M. DentiExecutive VP & Chief Commercial Officer · born 1968
- Mr. John C. FortsonExecutive VP & CFO · born 1967
- Mr. Kevin J. CzerneyVice President & Chief Accounting Officer · born 1984
- Mr. Kevin BoyleSenior VP & Chief Technology Officer
- Mr. John StevensSenior Vice President and Chief Information Officer
- Wade MoodySenior Manager of Investor Relations
- Ms. Lindi Barton-BrobstSenior VP & General Counsel